"Experimenal
Ebola medication ZMapp saves infected monkeys”
By:
Melissa Healy
Source:
LA Times
http://touch.latimes.com/#section/621/article/p2p-81216967/

Ebola is a fairly
new, fatal disease that has no cure. Recently, researchers have found that ZMapp,
an experimental drug, has cured about eighteen macaque monkeys that were
infected with the virus. The monkeys that were three days away from death had
treatment and were cured. Three infected macaques that did not get the
treatment were dead in eight days. Scientists from the San Diego Biotechnology
Company, which joined the Gary P. Kobinger Canadian Public Health Agency,
designed and developed ZMapp. Kobinger said that the antibodies that are being
cloned recognize and attach to the strains of the virus. The results for the
ZMapp cure were successful and they are hoping to test it on humans and save
lives. This is the most promising option right now for Ebola patients to get
cured. If a human is diagnosed with Ebola, the life span for that person will
be twelve to fourteen days. It is difficult to differentiate the timeline for
curing humans from the macaques but Kobinger concluded that there would no t be
a difference. In macaques the treatment showed no signs of harmful side
effects. Nature Study reported that if the disease reached the nervous system
of the macaque ZMapp was not able to treat it. It is still a mystery if ZMapp
will treat everyone in the future. Scientists are still running tests trying to
find a cure for patients suffering from Ebola.
It is important that an audience
should read this article because it shows how scientists are working their best
trying to find a cure for a terrible disease. People should be familiar with
ZMapp and other medications in case someone in their family is diagnosed.
No comments:
Post a Comment